Dawn Hill is the Vice President of clinical operations at QED Therapeutics. Ms. Hill brings more than 20 years of experience in clinical trial management, outsourcing and business development. Prior to joining QED she spent 7 year as Executive Director, Clinical Operations at OncoMed Pharmaceutics where she provided strategic oversight of multiple early phase oncology trials across 9 different compounds. Prior to OncoMed, she spent 14 years at a global full service CRO, Omnicare/Clinimetrics, as Vice President, Business Operations where she was responsible for US business development, project delivery and contract management. Early in her career, Ms. Hill also worked in clinical development at Chiron and Syntex Research. She earned a BS in Biochemistry from the University of California at Davis.